Cargando…

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database

Detalles Bibliográficos
Autores principales: Tacke, Frank, Tanios, Fady, Xie, Lin, Malhotra, Deepa, Dagenais, Simon, Katchiuri, Nino, Emir, Birol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252379/
http://dx.doi.org/10.1016/S0168-8278(22)00683-3
_version_ 1784740251056472064
author Tacke, Frank
Tanios, Fady
Xie, Lin
Malhotra, Deepa
Dagenais, Simon
Katchiuri, Nino
Emir, Birol
author_facet Tacke, Frank
Tanios, Fady
Xie, Lin
Malhotra, Deepa
Dagenais, Simon
Katchiuri, Nino
Emir, Birol
author_sort Tacke, Frank
collection PubMed
description
format Online
Article
Text
id pubmed-9252379
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92523792022-07-05 Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database Tacke, Frank Tanios, Fady Xie, Lin Malhotra, Deepa Dagenais, Simon Katchiuri, Nino Emir, Birol J Hepatol POSTER PRESENTATIONS: Thursday 23 June: NAFLD: Clinical aspects except therapy European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252379/ http://dx.doi.org/10.1016/S0168-8278(22)00683-3 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER PRESENTATIONS: Thursday 23 June: NAFLD: Clinical aspects except therapy
Tacke, Frank
Tanios, Fady
Xie, Lin
Malhotra, Deepa
Dagenais, Simon
Katchiuri, Nino
Emir, Birol
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database
title Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database
title_full Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database
title_fullStr Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database
title_full_unstemmed Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database
title_short Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database
title_sort non-alcoholic fatty liver disease (nafld)/non-alcoholic steatohepatitis (nash) is associated with worse outcomes in patients hospitalised for covid-19: a real-world analysis of a large population from the premier healthcare database
topic POSTER PRESENTATIONS: Thursday 23 June: NAFLD: Clinical aspects except therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252379/
http://dx.doi.org/10.1016/S0168-8278(22)00683-3
work_keys_str_mv AT tackefrank nonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnashisassociatedwithworseoutcomesinpatientshospitalisedforcovid19arealworldanalysisofalargepopulationfromthepremierhealthcaredatabase
AT taniosfady nonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnashisassociatedwithworseoutcomesinpatientshospitalisedforcovid19arealworldanalysisofalargepopulationfromthepremierhealthcaredatabase
AT xielin nonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnashisassociatedwithworseoutcomesinpatientshospitalisedforcovid19arealworldanalysisofalargepopulationfromthepremierhealthcaredatabase
AT malhotradeepa nonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnashisassociatedwithworseoutcomesinpatientshospitalisedforcovid19arealworldanalysisofalargepopulationfromthepremierhealthcaredatabase
AT dagenaissimon nonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnashisassociatedwithworseoutcomesinpatientshospitalisedforcovid19arealworldanalysisofalargepopulationfromthepremierhealthcaredatabase
AT katchiurinino nonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnashisassociatedwithworseoutcomesinpatientshospitalisedforcovid19arealworldanalysisofalargepopulationfromthepremierhealthcaredatabase
AT emirbirol nonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnashisassociatedwithworseoutcomesinpatientshospitalisedforcovid19arealworldanalysisofalargepopulationfromthepremierhealthcaredatabase